The extent of long COVID and its characteristics among the older population ISID_org longCOVID coronavirus covid
By Bhavana KunkalikarOct 5 2022Reviewed by Danielle Ellis, B.Sc. In a recent study published in the International Journal of Infectious Diseases, researchers explored the characteristics of long coronavirus disease among older adults.
The five multidisciplinary hospital-based COVID-19 recovery centers in Israel, Switzerland, Spain, and Italy participated in this multicenter prospective cohort study. Consecutive adult patients who visited the facilities between May 2020 and March 2021 and were over 18 years were included. Patients had to have a COVID-19 diagnosis confirmed by polymerase chain reaction at least 30 days before the clinic visit to be enrolled for a visit.
Results The study included a total of 2333 individuals. The average age was 51 years, while 20.5% of the population was over 65 years. The average amount of time between the COVID-19 onset and the visit to the clinic was 146 days. Compared to the percentage of women in the younger group, the proportion of women over 65 was lower. The prevalence of smoking, inactivity, comorbidities, and medication use were all higher among older people.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Multiomic comparison shows a reduction in circulating monocytes correlated with persistent post-COVID-19 pulmonary fibrosisIn a new study, researchers identified distinguishing immune features of coronavirus disease 2019 (COVID-19) in patients with late-resolving pulmonary fibrosis (LR COVID-PF) and early-resolving (ER COVID-PF).
Consulte Mais informação »
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control studyObjective To estimate the effectiveness of mRNA vaccines against moderate and severe covid-19 in adults by time since second, third, or fourth doses, and by age and immunocompromised status. Design Test negative case-control study. Setting Hospitals, emergency departments, and urgent care clinics in 10 US states, 17 January 2021 to 12 July 2022. Participants 893 461 adults (≥18 years) admitted to one of 261 hospitals or to one of 272 emergency department or 119 urgent care centers for covid-like illness tested for SARS-CoV-2. Main outcome measures The main outcome was waning of vaccine effectiveness with BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) vaccine during the omicron and delta periods, and the period before delta was dominant using logistic regression conditioned on calendar week and geographic area while adjusting for age, race, ethnicity, local virus circulation, immunocompromised status, and likelihood of being vaccinated. Results 45 903 people admitted to hospital with covid-19 (cases) were compared with 213 103 people with covid-like illness who tested negative for SARS-CoV-2 (controls), and 103 287 people admitted to emergency department or urgent care with covid-19 (cases) were compared with 531 168 people with covid-like illness who tested negative for SARS-CoV-2. In the omicron period, vaccine effectiveness against covid-19 requiring admission to hospital was 89% (95% confidence interval 88% to 90%) within two months after dose 3 but waned to 66% (63% to 68%) by four to five months. Vaccine effectiveness of three doses against emergency department or urgent care visits was 83% (82% to 84%) initially but waned to 46% (44% to 49%) by four to five months. Waning was evident in all subgroups, including young adults and individuals who were not immunocompromised; although waning was morein people who were immunocompromised. Vaccine effectiveness increased among most groups after a fourth dose in whom this booster was recommended. Conclusions Effecti
Consulte Mais informação »
Can you shed infectious SARS-CoV-2 virions even if COVID vaccinated?Researchers in the United States published a study in the journal PLOS Pathogens that examined the shedding of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virions despite vaccination against it.
Consulte Mais informação »
Covid hospital admissions rise 50 per cent in a week fuelling 'new wave' fearsThe number of patients in hospital with covid has risen sharply for the first time since the peak of the last wave
Consulte Mais informação »
COVID-19 vaccination offers sustained and potent neutralizing protection against variants compared to natural infectionCOVID-19 vaccination offers sustained and potent neutralizing protection against variants compared to natural infection everly_well CUAnschutz medrxivpreprint COVID19 SARSCoV2 Vaccination Variants NaturalInfection
Consulte Mais informação »